Board Meetings for MARKSANS

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
MARKSANSMarksans Pharma Limited30 May 2015Results/Dividendinter alia, to consider and approve Audited Financial Results of the Company for the financial year ended March 31, 2015 and to consider recommendation of dividend, if any, for the financial year ended March 31, 2015.
MARKSANSMarksans Pharma Limited07 Feb 2015ResultsInter alia to consider and approve Unaudited Financial Results for the Quarter ended 31st December, 2014.
-
MARKSANSMarksans Pharma Limited31 Oct 2014ResultsInter alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended September 30, 2014.
-
MARKSANSMarksans Pharma Limited12 Aug 2014ResultsInter alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended June 30, 2014.
MARKSANSMarksans Pharma Limited29 May 2014Results/DividendInter alia to consider and approve Annual Audited Financial Results of the Company for the financial year ended March 31, 2014 and to consider recommendation of dividend, if any, for the financial year ended March 31, 2014.
MARKSANSMarksans Pharma Limited03 Feb 2014ResultsTo consider and approve Unaudited Financial Results of the Company for the quarter ended December 31, 2013.
-
MARKSANSMarksans Pharma Limited31 Oct 2013ResultsTo consider and approve Unaudited Financial Results of the Company for the Quarter ended on September 30, 2013.
-
MARKSANSMarksans Pharma Limited29 Jul 2013ResultsTo consider and approve Unaudited Financial Results of the Company for the Quarter ended June 30, 2013.
-
MARKSANSMarksans Pharma Limited27 May 2013ResultsTo consider and approve Annual Audited Financial Results of the Company for the financial year ended on March 31, 2013.
-
MARKSANSMarksans Pharma Limited14 Feb 2013ResultsTo consider and approve Unaudited Financial Results of the Company for the Quarter ended on December 31, 2012.
-
MARKSANSMarksans Pharma Limited14 Dec 2012Issue of SecuritiesTo consider conversion of warrants and issue and allot in lieu thereof 1,75,00,000 Equity Shares of Re.1/- each to Mr. Mark Saldanha,Promoter of the Company on preferential allotment basis.
-
MARKSANSMarksans Pharma Limited12 Nov 2012Un-audited Financial ResultsTo consider and approve Unaudited Financial Results of the Company for the Quarter ended on September 30, 2012.
-
MARKSANSMarksans Pharma Limited14 Aug 2012Un-audited Financial ResultsTo consider and approve Unaudited Financial Results of the Company for the Quarter ended June 30, 2012.
-
MARKSANSMarksans Pharma Limited29 May 2012Audited Financial ResultsTo consider and approve Annual Audited Financial Results for the financial year ended on March 31, 2012.
-
MARKSANSMarksans Pharma Limited13 Feb 2012Un-audited Financial ResultsTo consider and approve Unaudited Financial Results for the Quarter ended on December 31, 2011.
-
Showing page 5 of 9 (121 total items)